A novel molecular communication inspired detection method for the evolution of atherosclerosis

Yue Sun1, Meiling Liu2, Yue Xiao2

  • 1School of Mechanical and Electrical Engineering, Chengdu University of Technology, Chengdu 610059, China; School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 611731, China.

Insights

This study introduces a novel molecular communication method for early atherosclerosis detection. The technique uses nanoparticle (NP) arrival probability to assess arterial stenosis, offering a simpler, low-cost diagnostic approach.

Area of Science:

  • Biomedical Engineering
  • Molecular Communications
  • Cardiovascular Disease Research

Background:

  • Atherosclerosis causes arterial thickening and plaque buildup, restricting blood flow and leading to serious cardiovascular diseases.
  • Early detection of atherosclerosis is crucial for risk mitigation, yet reliable methods for early-stage identification are lacking.
  • This research explores molecular communications as a novel paradigm for atherosclerosis detection.

Purpose of the Study:

  • To propose and evaluate a new method for detecting atherosclerosis using molecular communications.
  • To assess the degree of arterial stenosis by analyzing nanoparticle (NP) behavior in blood vessels.
  • To develop a low-cost and straightforward early detection technique for atherosclerosis.

Main Methods:

  • Utilized COMSOL for physical field modeling, coupling fluid and particle tracking modules.
  • Mapped contrast agent into nanoparticles (NPs) and simulated their propagation through stenosed arteries.
  • Defined NP arrival probability as the ratio of NPs reaching the outlet to the total released, analyzing changes due to stenosis.
  • Introduced a multi-release method to enhance detection sensitivity by increasing overlapping NP concentrations.

Main Results:

  • NP arrival probability was found to be affected by dynamic flow changes, reflecting arterial stenosis degree.
  • Poincaré maps of NP arrival probability were analyzed to assess stenosis from early to late stages.
  • The multi-release method demonstrated more prominent data differences compared to a single-release method, enhancing observable results.

Conclusions:

  • A novel atherosclerosis detection method based on molecular communication was proposed, evaluating arterial stenosis via NP emission and reception data.
  • The method enables simple, early-stage disease detection and direct quantification of pathological processes.
  • This approach offers a straightforward way to assist clinicians and potentially reduce traditional detection costs.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
141
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54
Inflammation01:38

Inflammation

Overview
55.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
67